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The peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) controls metabolic 
adaptations. We now show that PGC-1α in skeletal muscle drives the expression of lactate 
dehydrogenase (LDH) B in an estrogen-related receptor α (ERRα)-dependent manner. 
Concomitantly, PGC-1α reduces the expression of LDH A and one of its regulators, the 
transcription factor Myc. PGC-1α thereby coordinately alters the composition of the LDH 
complex and prevents the rise in blood lactate during exercise. Our results show how PGC-1α 
actively coordinates lactate homeostasis and provide a novel molecular explanation for PGC-
1α-mediated muscle adaptations to training that ultimately enhance exercise performance and 





Skeletal muscle adaptations to endurance exercise are largely mediated by PGC-1α (reviewed 
in (1, 2)). Elevated expression of PGC-1α in skeletal muscle is consequently sufficient to 
mimic an endurance-trained phenotype (3), which is partially achieved by a pronounced fiber-
type switching from fast, glycolytic towards slow, oxidative fibers, including slow fiber type-
specific calcium handling (4, 5). Additionally, PGC-1α improves oxygen supply to muscle by 
promoting angiogenesis (6) and remodels the neuromuscular junction (7). Most importantly, 
however, PGC-1α alters skeletal muscle metabolism by inducing mitochondrial biogenesis (5, 
8) and promoting lipid oxidation (9). However, PGC-1α also drives anabolic processes like 
lipid (10) and glucose refueling in skeletal muscle (11). Concomitantly, substrate flux through 
glycolysis is inhibited by elevated levels of PGC-1α (11) while pentose phosphate pathway 
activity is increased (10). 
 
Exercise performance and lactate synthesis are strongly linked (12). For example, strenuous 
exercise leads to the production of lactate in working skeletal muscles and to a steady increase 
in blood lactate levels. Inversely, regular training counters the excessive rise in blood lactate 
levels as indicated by the reduced blood lactate levels in trained athletes during acute exercise 
bouts (13). Similarly, reduced basal and post-exercise blood lactate levels have previously 
been reported in mice with elevated levels of PGC-1α in skeletal muscle (11). However, it is 
unclear whether this observation is caused by diminished lactate generation, enhanced lactate 
clearance or both. Moreover, the molecular mechanisms that underlie the putative PGC-1α-
mediated reduction in blood lactate levels are unknown. We hypothesized that PGC-1α 
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actively drives a transcriptional program to enhance lactate metabolism and have now 





PGC-1α in skeletal muscle controls whole body lactate levels 
Since exhaustive exercise boosts blood lactate levels, we first investigated the impact of PGC-
1α in skeletal muscle on whole body lactate homeostasis. During a maximal endurance 
performance test, blood lactate levels continuously increased in wild-type mice and returned 
to basal levels within 40mins following fatigue-induced exercise cessation (Fig. 1A, B). In 
stark contrast, blood lactate levels did not substantially rise in muscle-specific PGC-1α 
transgenic (MPGC-1α TG) animals during exercise at any point (Fig. 1A, B). Since skeletal 
muscle is the main site for lactate production, we next assessed the mRNA expression of 
lactate dehydrogenase A (LDH A), which encodes for the LDH muscle subunit (M) that 
metabolizes pyruvate to lactate (14). LDH A mRNA expression in tibialis anterior was 
decreased by 53.5% (p<0.001) in MPGC-1α TG animals compared to control littermates (Fig. 
1C). Consistently, the enzymatic activity of LDH-mediated pyruvate to lactate conversion 
was diminished by 40.1% (p<0.001) in skeletal muscle of transgenic animals (Fig. 1D). These 
differences in LDH A mRNA expression and activity between MPGC-1α TG and control 
animals persisted in response to an acute bout of exercise (Fig. S1A, B).  
To test whether lactate removal is also altered by PGC-1α, lactate tolerance tests were 
performed. The excursion (Fig. 1E) and total area under the curves (Fig. 1F) clearly show 
that MPGC-1α TG animals more efficiently cleared lactate from the circulation compared to 
control animals. To further characterize the enhanced capacity of muscle for lactate clearance, 
we determined the mRNA expression of LDH B which encodes for the LDH heart subunit (H) 
that drives the conversion of lactate to pyruvate (14). LDH B mRNA expression in tibialis 
anterior was significantly elevated in MPGC-1α TG animals by 110.2% (p<0.001) (Fig. 1G). 
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Moreover, the enzymatic activity of LDH to convert lactate to pyruvate was enhanced by 
60.7% (p<0.01) (Fig. 1H). In response to exercise, LDH B mRNA levels did not change, but 
LDH B activity further increased in MPGC-1α TG animals (Fig. S1C, D). 
 
PGC-1α drives LDH isoenzyme-type switching in skeletal muscle 
The tetrameric lactate dehydrogenase complex consists of LDH M and H subunits (14, 15). 
According to its subunit composition, the complex is referred to as LDH 1 (H4), LDH 2 
(H3M), LDH 3 (H2M2), LDH 4 (HM3) or LDH 5 (M4) (14, 16). To gain insights into the 
individual isoenzyme composition of wild-type and MPGC-1α TG animals, we performed 
native gel electrophoresis of muscle homogenates (Fig. 1I). MPGC-1α TG animals displayed 
a pronounced shift towards an isoenzyme composition enriched in LDH H subunits, namely 
LDH 1, 2 and 3 (Fig. 1I, J). In contrast, protein levels of LDH 5, which exclusively contains 
LDH M subunits, were reduced in MPGC-1α TG animals (Fig. 1I, J). 
 
Elevated capacity for lactate uptake in MPGC-1α TG animals 
Given the enhanced potential of skeletal muscle of MPGC-1α TG animals to convert lactate to 
pyruvate, we also investigated the mRNA expression of key genes implicated in lactate 
import and export in this organ. Relative mRNA levels of MCT1, which mediates lactate 
import into muscle (17) and mitochondria (18) was significantly increased in MPGC-1α TG 
animals (Fig. 1K). In contrast, the mRNA levels of MCT4, which exports lactate (17), and 
CD147, an ancillary molecule of MCT1 and 4 (19), were both unaltered (Fig. 1K). The 
elevated muscle MCT1 content in MPGC-1α TG animals is consistent with the enhanced 
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whole-body lactate removal during lactate tolerance tests and with the previous demonstration 
that PGC-1α increases lactate uptake into skeletal muscle (20). 
 
PGC-1α promotes LDH B transcription by co-activating ERRα on the LDH B promoter 
Biocomputational predictions were then applied to unravel the potential molecular mechanism 
by which PGC-1α promotes LDH B and MCT1 transcription. To this end, microarray data 
from differentiated C2C12 myotubes adenovirally infected with either GFP or bicistronic 
GFP-PGC-1α (21) were analyzed. We first used Motif Activity Response Analysis (MARA) 
to identify motifs that are most active following overexpression of PGC-1α (Fig. 2A). Then, 
we screened the lactate dehydrogenase B and the MCT1 promoters for putative binding sites 
for transcription factors. No transcription factors were found in the MCT1 promoter that 
showed a high activity in MARA. In contrast, there were two transcription factors that 
displayed very high activities in MARA and concomitantly were predicted to bind to the LDH 
B promoter, namely the estrogen-related receptor α (ERRα) and retinoid X receptors (RXRs) 
(Fig. 2A, Fig. S2). Recruitment of ERR to the LDH B promoter has previously been 
reported in global ChIP-on-ChIP assays in mouse liver cells; however, the functional 
consequences of this observation have not been investigated (22).  
To experimentally verify our biocomputational predictions, pharmacological inhibitors and 
siRNA silencing technology for ERRα and RXR were used. In differentiated C2C12 
myotubes, PGC-1α led to a very robust induction of LDH B, which was completely prevented 
by the ERRα inverse agonist XCT-790 (Fig. 2B). Inhibition of RXRs by HX-531 likewise 
resulted in a significant reduction in PGC-1α-mediated induction of LDH B, however to a 
smaller extent compared to ERRα inhibition (Fig. 2B). Similarly, RNA silencing of ERRα in 
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myoblasts led to a significant reduction in LDH B expression, while silencing of RXRα or β 
reduced LDH B expression to a smaller extent (Fig. S3). 
Interestingly, analysis of the LDH B promoter (http://www.swissregulon.unibas.ch) (23) 
identified overlapping binding sites for ERRα and RXR in the LDH B promoter (Fig. S4A). 
Using chromatin immunoprecipitated DNA from muscle samples, we confirmed that PGC-1α 
is recruited to the ERRα/RXR binding site on the proximal LDH B promoter (Fig. 2C). 
Moreover, activation of a 684bp fragment of the LDH B promoter by PGC-1α in reporter 
gene assays was dependent on functional integrity of the ERRα response element (Fig. S4B 
and C). In contrast, association of PGC-1 with the recently identified distal MEF2 binding 
site in the LDH promoter region (24) was not elevated in MPGC-1α TG mice compared to 
wild-type controls (Fig. 2C). In line with this finding, pharmacological inhibition of the 
MEF2 upstream activator PPARβ/δ did not prevent PGC-1α-mediated LDH B transcription 
(Fig. S5). 
 
Decreased levels of LDH A and Myc in MPGC-1α TG animals 
LDH A transcription is regulated by HIF-1α (hypoxia-inducible factor 1 α) and Myc 
(myelocytomatosis oncogene) (25). While HIF-1α mRNA levels were similar in wild-type 
and transgenic animals, Myc transcript levels were reduced in skeletal muscle of MPGC-1α 
TG mice compared to controls (Fig. 2D). Consistently, protein levels of Myc were also 
significantly decreased in MPGC-1α TG mice compared to their control littermates (Fig. 2E, 
F). Interestingly, the administration of AM6-36, a drug that binds to RXR responsive 
elements and mimics the effects of RXRs, has recently been reported to abrogate Myc 
expression (26, 27). Indeed, also in our experimental context, pharmacological inhibition of 
10 
 
RXRs by HX-531 was sufficient to restore Myc (Fig. 2G) and consequently LDH A 
expression (Fig. 2H). 
 
Increased levels of MCT1 and decreased levels of LDH A are not caused by elevated LDH 
B  
To investigate whether the increased MCT1 and the decreased LDH A levels constitute a 
secondary effect of LDH B induction, we next inhibited LDH B transcription in differentiated 
C2C12 myotubes. While LDH B transcription was successfully reduced in this experiment 
(Fig. S6A), the effect of PGC-1α on MCT1 and LDH A persisted (Fig. S6B, C). 
 
Selective regulation of muscle lactate homeostasis by PGC-1β 
Since PGC-1α and β exert similar effects, we also examined the potential impact of PGC-1β 
on LDH B, LDH A and MCT1 mRNA levels. Overexpression of PGC-1β in differentiated 
C2C12 myotubes resulted in elevated levels of LDH B (Fig. S6D), but the effect was less 
pronounced than with PGC-1α (Fig. 2B). LDH A levels were reduced, but MCT1 levels 
unaltered following overexpression of PGC-1β (Fig. 6E and F). Importantly however, PGC-
1β is not induced in skeletal muscle by exercise (28) and might thus be less relevant in 
mediating altered lactate handling in the adaptation to exercise. 
 




To corroborate the importance of PGC-1α in regulating lactate homeostasis, and especially 
LDH B expression, we then studied mice with a muscle-specific knock-out of PGC-1α. 
MPGC-1α KO animals fatigued rapidly and accumulated blood lactate to a higher extent than 
their control littermates in endurance exercise trials (Fig. 3A, B). LDH A mRNA showed a 
non-significant trend towards higher expression in MPGC-1α KO animals (Fig. 3C). Myc 
mRNA did not differ beween MPGC-1α KO and control animals (Fig. S7). In terms of lactate 
tolerance, MPGC-1α KO animals were less efficient in lactate clearance upon injection of 
lactate (Fig. 3D, E). Consistently, MPGC-1α KO animals displayed a significant reduction of 
LDH B expression (Fig. 3F). Moreover, the analysis of LDH isoenzyme composition revealed 
lower levels of isoenzymes typically enriched in H subunits (Fig. 3G, H, I). Together, these 
data clearly demonstrate that muscle PGC-1α is important for the transcription of LDH B and 
for maintaining whole body lactate homeostasis. 
Acute bouts of exercise had no effect on LDH A mRNA expression, but led to a significant 
increase in LDH A activity in control animals (Fig. S8A, B). In MPGC-1α KO mice- LDH A 
activity was already elevated at the basal state and was not further inducible by exercise (Fig. 
S8B). LDH B mRNA levels and activity were lower in MPGC-1α KO animals and these 
differences persisted after exercise (Fig. S8C, D). 
 
The low blood lactate levels in MPGC-1α TG are not due to altered metabolism in heart or 
liver 
Besides skeletal muscle, liver and heart play important roles in buffering blood lactate levels 
(29, 30). In the “Cori Cycle”, the liver takes up lactate and converts it into pyruvate, which 
then serves as a substrate for gluconeogenesis. Glucose can subsequently be transported back 
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to different organs including skeletal muscle, where it is again metabolized to lactate. In 
contrast, the heart directly uses lactate as energy source (29). Lactate is completely oxidized 
to water and carbon dioxide in the heart and is even preferred as energy source compared to 
glucose (29). We thus analyzed the mRNA levels of genes involved in lactate production, 
removal and transport in these two tissues. In the heart, no differences in mRNA expression 
between wild-type and transgenic animals were observed (Fig. 4A). In the liver, there was a 
significant increase in CD147 mRNA levels, while the other genes remained unchanged (Fig. 
4B). Analogous to our studies in skeletal muscle, we subsequently assessed the enzymatic 
activities of LDH in heart and liver. The conversion of pyruvate to lactate was significantly 
reduced in the heart (Fig. 4C), while the conversion of lactate to pyruvate was unaltered (Fig. 
4D). In the liver, no changes in LDH activity were detectable (Fig. 4E, F). Iso-enzyme 
compositions between MPGC-1α TG and wild-type animals were undistinguishable for both 
the heart (Fig. 4G, H) and the liver (Fig. 4I, J). An acute bout of exercise affected LDH in 
both tissues. In the heart, exercise increased LDH A activity in wild-type, but not in MPGC-
1α TG mice (Fig. S9). Cardiac LDH B mRNA levels and activity were both induced by 
exercise to a similar extent in both genotypes (Fig. S9C, D). The liver was less responsive to 




Disarranged metabolism in skeletal muscle is a common, early event in the etiology of obesity 
and type 2 diabetes. One trait of these diseases is a decreased oxidative capacity along with 
elevated lactate production (31, 32). Remodeling of the muscular metabolic profile might thus 
constitute a potential approach to treat or prevent such disorders (33). Exercise is one of the 
most important stimuli for improving the metabolic phenotype of skeletal muscle. Glucose 
and lipid metabolism are extensively altered in response to chronic exercise, largely mediated 
by PGC-1α (reviewed in (1, 2)). We have now shown that PGC-1α also is a key regulator of 
tissue and systemic lactate homeostasis.  
Intriguingly, a shift towards a muscle LDH isoenzyme composition enriched in LDH H 
subunits has been observed in mice and humans in response to chronic electrical stimulation 
and regular endurance exercise, respectively (34, 35). The molecular mechanism that underlay 
the remodeling of the LDH complex remained, however, unresolved. Our study now 
demonstrates that this adaptation to exercise is directly mediated by the interaction of PGC-1α 
and ERRα and, moreover, that PGC-1α is required for the elevated LDH B transcription and 
proper lactate homeostasis during exercise. PGC-1α thus remodels LDH isoenzyme 
composition distinctly and independently of coactivation of PPARβ/δ, which recently has 
been described to drive LDH B transcription via MEF2 activation in a distal enhancer region 
of LDH B (24). In addition, PGC-1α reduces LDH A gene expression, which could 
potentially counteract the enzymatic activity of LDH B of converting lactate into pyruvate. 
How PGC-1α, a transcriptional co-activator, can exert repressive effects remains elusive. A 
previous study revealed that stimulation of mitochondrial activity diminishes Myc expression 
(36). Conceivably, the PGC-1α-mediated boost in mitochondrial activity might repress Myc 
expression analogously. In addition, our results demonstrating restoration of Myc following 
14 
 
RXR inhibition strongly suggest a role of RXRs in regulating Myc expression. This is further 
underlined by our previous data showing induction of RXRs gene expression in skeletal 
muscle by PGC-1α (10). Furthermore, in the present study, we found RXR binding motifs to 
be predicted to be associated with PGC-1α-dependent gene expression in muscle cells by 
MARA. However, a detailed analysis of the mechanistic aspects of the repression of LDH A 
gene transcription by the transcriptional co-activator PGC-1 through Myc is hampered by 
the very low expression of Myc in skeletal muscle (37). Importantly, our findings that PGC-
1α elevates LDH H and diminishes LDH M subunit expression are further corroborated by 
mouse and human studies on muscle beds with different fiber type compositions. In fact, fast-
twitch muscles, which typically express low levels of PGC-1α display high amounts of LDH 
M subunits, while the LDH complexes in slow-twitch muscles with higher expression of 
PGC-1α are enriched in LDH H subunits (38, 39). 
Lactate production is important in working muscle to maintain glycolytic fluxes for ATP 
production (15, 40). Presumably, the conversion of pyruvate to lactate rapidly regenerates 
NAD+ from NADH. This requirement is mainly due to the limited pool of cytosolic NAD+ in 
skeletal muscle (25). The prevention of NAD+ regeneration by PGC-1α and the lower levels 
of the transcription factor Myc, a well-known activator of glycolysis (41) now suggest a 
molecular explanation for the reduced glycolytic rates occurring at high PGC-1α levels in 
muscle (11). Moreover, the potentially enhanced production of NADH by lactate oxidation 
triggered by PGC-1α ensures adequate levels of this cofactor for the electron transport chain 
and thus for ATP generation during muscle contractions. This concept of lactate as energy 
source during acute exercise is corroborated by previous studies showing that lactate 
oxidation was higher in exercising compared to resting muscle (42-44). 
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Importantly, our study also sheds new light onto the role of lactate in skeletal muscle fatigue. 
For many decades lactate was considered as a side product of contracting muscle and viewed 
as a metabolite that causes muscle fatigue. MPGC-1α TG animals display reduced lactate 
levels and are more resistant to fatigue, which would further support the concept of lactate as 
fatiguing metabolite. Importantly however, MPGC-1α TG animals reach exhaustion at a time 
point when blood lactate levels are still in a normal range, indicating that factors other than 
lactate contribute to muscle fatigue. 
Recently, the perception of lactate as a harmful metabolite has drastically waned (12, 45). 
During exercise, lactate accumulation and mild lactic acidosis cause vasodilatation and 
dissociation of oxygen from hemoglobin and thus oxygen transport to muscle. In this context, 
the reduction in blood lactate levels by PGC-1α might be viewed as a performance-limiting 
factor during strenuous exercise. However, PGC-1α likely overcomes this effect by increasing 
myoglobin expression (4) and enhancing angiogenesis (6). 
In conclusion, we have demonstrated that PGC-1α and ERRα orchestrate the transcription of 
LDH B, that PGC-1α reduces the levels of the oncogenic LDH A activator Myc and that the 
subsequent shift in LDH composition promotes lactate oxidation in skeletal muscle. Lactate 
produced during exercise by predominantly glycolytic muscles is thus used as fuel in 
oxidative muscle fibers that express elevated levels of PGC-1α. Importantly, our results 
suggest a direct regulatory role for PGC-1α in the metabolic remodeling of lactate 
metabolism. Thus, by driving lactate uptake and oxidation, PGC-1α promotes alternative 
metabolic pathways for energy generation during muscle contraction. Finally, ectopic PGC-1α 
antagonizes the disarranged lactate metabolism observed under pathological conditions such 
as type 2 diabetes and obesity, in addition to restoring mitochondrial functions. Our results 
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therefore provide new insights into the molecular mechanisms by which PGC-1α 




Materials and Methods 
 
Animals 
Male muscle-specific PGC-1α transgenic mice (MPGC-1α TG) (4), muscle-specific PGC-1α 
knock-out mice (MPGC-1α KO) (46) and control littermates were maintained in a 
conventional facility with a fixed 12-h light/dark cycle on a commercial pellet chow diet and 
free access to tap water. Studies were performed with 8 weeks old animals according to 
criteria outlined for the care and use of laboratory animals and with approval of the Swiss 
authorities. 
 
Treadmill running and lactate tolerance tests 
Detailed description in the supplementary material. 
 
RNA extraction and RT-PCR 
Frozen tissues were homogenized under liquid nitrogen and total RNA was isolated using 
Trizol reagent (Invitrogen). RNA concentrations were adjusted and reverse transcription was 
carried out using random hexamer primers (Promega). Real-time PCR analysis (Power SYBR 
Green Master Mix, Applied Biosystems) was performed using the StepONE Detector. 
Relative expression levels for each gene of interest were calculated with the Ct method and 
normalized to the expression of the Tata box binding protein (TBP). 
 
Lactate dehydrogenase activity  
Specific lactate dehydrogenase activities (pyruvate to lactate and lactate to pyruvate 
conversions) were determined according to Howell et al (47). The enzymatic reactions were 
carried out either in the presence of 1mmol sodium pyruvate and 150µmol NADH or of 
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7mmol lactic acid and 5.5mmol NAD+. Changes in absorbance were assessed by a 
spectrophotometer at 340nm and 30°C. 
 
Isoenzyme shift 
LDH isoenzyme patterns were determined colorimetrically. Protein isolation from tibialis 
anterior was performed as described previously (48). Twenty, 50 and/or 100 μg of protein 
were loaded onto a 6% native polyacrylamide gel. Following electrophoresis, the gel was 
stained in 10 mL of staining solution containing 0.1 M sodium lactate, 1.5 mM NAD+, 0.1 M 
Tris-HCl (pH 8.6), 10 mM NaCl, 5 mM MgCl2, 0.03 mg/mL phenazinmethosulphate (PMS), 
and 0.25 mg/mL nitrobluetetrazolium (NBT). 
 
Cell culture experiments 
C2C12 myoblasts were fused into myotubes and infected with adenovirus expressing GFP or 
bicistronic PGC-1α-GFP. The transfection efficiency was similar between GFP and PGC-1α-
GFP and PGC-1α-GFP efficiently increased PGC-1α protein levels (Fig. S11). In addition, 
cells were treated for 48 h with 0.1% DMSO (as control), 10 μM XCT-790 (Sigma-Aldrich) 
to inhibit ERRα or 2 μM HX-531 (Tocris Bioscience) to inhibit RXRs, together with the 
corresponding adenovirus. Silencing of LDH B, ERRα, RXRα and RXRβ was performed 
using Dharmacon smartpool siRNAs according to the manufacturer’s instructions. 
 
ChIP assays 
Detailed description in the supplementary material. 
 
LDH B promoter cloning and reporter gene assays 
Detailed description in the supplementary material. 
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Bioinformatics, data analysis and statistics 
Detailed description in the supplementary material. 
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SUPPORTING INFORMATION MATERIALS AND METHODS 
 
Treadmill running 
Treadmill running was performed on a motorized treadmill (Columbus Instruments) equipped 
with an electric shock grid. After acclimatization, the mice were forced to run till exhaustion. 
The detailed protocol was as follows: 10m/min for 5min and increase by 2m/min every 5 
minutes until 26m/min with 5° inclination. The speed of 26m/min was then kept until 
exhaustion. The experiments were conducted according to established guidelines (49). Tissues 
were harvested 3 hrs post-exercise. 
 
Lactate tolerance test 
Lactate tolerance test was performed following i.p. injection of 2g/kg body weight of lactate. 
Blood was obtained at intervals of 10 minutes from the tail vein, and lactate levels were 
determined using a standard lactometer (Nova Biomedical). 
 
ChIP assays 
Chromatin immunoprecipitation from muscle tissue was performed as previously described 
(10). In brief, muscle tissues were fixed in 1.5% formaldehyde at room temperature for 
15mins. The reaction was stopped by adding glycine and tissues were homogenized on ice 
using a Dounce homogenizer (20strokes). Following cell lysis, chromatin was enzymatically 
sheared and subjected to immunoprecipitation using anti-PGC-1α antibodies (PGC-1 (H-300), 
Santa Cruz Biotechnology) or unrelated IgG bound to protein G-coupled magnetic beads. 





Previously published microarray data from differentiated C2C12 myotubes adenovirally 
infected with GFP or bicistronic PGC-1α-GFP under the cytomegalo virus (CMV) promoter 
(GEO Data set: GSE4330, ref. (21)) were analyzed using Motif Activity Response Analysis 
(http://www.mara.unibas.ch/cgi/mara). Prediction of potential transcription factors binding to 
the LDH B promoter were performed with SwissRegulon 
(http://www.swissregulon.unibas.ch) (23). 
 
LDH B promoter cloning and reporter gene assays 
 
A 681-bp fragment of the LDH B promoter was amplified using the primers LDHB prom 
forward (CGACGCGTGG AGGAACTGTG AAAGGCAGAA ATC) and LDHB prom 
reverse (GAAGATCTGC AAAGTCAGCA GGCTGCTGCT CTGC), which added an MluI 
and BglII restriction sites to the 5’ and 3’ ends of the PCR product, respectively. This 
promoter fragment was subcloned into the pGL3 basic luciferase reporter gene vector 
(Promega) and subsequently validated by sequencing. Site-directed mutagenesis of the ERRα 
response element in the LDH B promoter was performed by using the following, overlapping 
mutagenesis primers: ERRa mut forward CAGCGGAAGG GGTACCCTAA 
CTTTAGAGAG C and ERRa mut reverse CTAAAGTTAG GGTACCCCTT 
CCGCTGAGGC AC. The nucleotides depicted in bold represent the mutagenesis of the core 
ERRα response element in the LDH B promoter (TGACCT) into a KpnI restriction site. The 
plasmid with the mutated promoter was verified by sequencing. 
Reporter gene assays were performed on 12 well plate using C2C12 myoblasts and COS-7 
cells. Cells were transfected using LipofectamineTM 2000 (Invitrogen) with 0.1 μg pRL-
SV40 (Promega: E2231) and 0.7 μg pLDHB-luc or pLDHB-mut-luc. Total amount of plasmid 
DNA was kept constant at 1.6 μg per well by using the control plasmid pShuttle-CMV 
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(ATCC). Twenty four hours after transfection cells were infected with GFP or PGC-1α 
adenovirus for another 24 h. Following a total period of 48 h, cells were lysed with 250 μL of 
1X Passive Lysis 5X Buffer (Promega) and luciferase activity was measured in 75 μL of 
lysate in a 96 well plate using the Dual-Glo® Luciferase Assay System (Promega). Renilla 
(pRL-SV40) luciferase activity was used for normalization. Two independent experiments 
were performed in triplicate each. 
 
Data analysis and statistics 
All data are presented as means ± SE. The data were analyzed by Student's two-tailed 
unpaired t test or the Mann-Whitney test when the difference between the two S.D. values 
was significantly different. For the analysis of pharmacological inhibition, multifactorial 
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